chevron_leftBack
Guizhou Bailing Group Pharmaceutical Co., Ltd.
002424
5.03CNY
-1%
0.7433 USD
As of 14 June 2026, Guizhou Bailing Group Pharmaceutical Co., Ltd. has a market cap of $1.02B USD, ranking #10572 globally and #2958 in China.
It ranks #946 in the Healthcare sector, and #352 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.02BUSD
6.93B CNY
Enterprise Value
$1.17BUSD
7.9B CNY
Revenue (TTM)
$432.73MUSD
2.93B CNY
EBITDA (TTM)
$50.48MUSD
341.58M CNY
Net Income (TTM)
-$14.81MUSD
-100.35M CNY
EBITDA Margin
12%
Profit Margin
-3.4%
PS Ratio
2.4
PB Ratio
2.2
EV/EBITDA
22.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Min Niu
open_in_new
Employees
6,586
Founded
1999
Website
gzbl.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1% | 1% | 4.1% | 19% | -15% | 28% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002424
贵州百灵企业集团制药股份有限公司 Class A
ISIN: CNE100000PY3
Shares Out.:
Shares Outstanding:
1.181B1
Shares Float:
1.078B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5.03 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headquartered in Anshun, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
5K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
5K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
3K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
1K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
74K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
53K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
35K%
|
97.4
|
|
SIX: RO
|
$321.52B
31K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
28K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
27K%
218.9B CHF
|
20.5
|
chevron_leftBack